Recombinant Factor VIIa and the Trauma Patient

Journal of Emergency Nursing

Volumn 32, Issue 5, 2006, Pages 404-408

  Criddle, Laura M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG COST; DRUG LABELING; DRUG MONITORING; ECONOMICS; EMERGENCY NURSING; EMERGENCY TREATMENT; HEMOSTASIS; HUMAN; INJURY; METHODOLOGY; NURSE ATTITUDE; NURSING; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAFETY; TIME; TREATMENT OUTCOME;

DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; DRUG LABELING; DRUG MONITORING; EMERGENCY NURSING; EMERGENCY TREATMENT; FACTOR VII; FACTOR VIIA; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; NURSE'S ROLE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; SAFETY; TIME FACTORS; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 33748709223     PISSN: 00991767     EISSN: 15272966     Source Type: Journal    
DOI: 10.1016/j.jen.2006.08.015     Document Type: Article

References (25)

1. Barletta J., Ahrens C., Tyburski J., and Wilson R. A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients. J Trauma Inj Infect Crit Care 58 (2005) 646-651
2. Welsby I., Monroe D., Lawson J., and Hoffman M. Recombinant activated factor VII and the anesthetist. Anesthesia 60 (2005) 1203-1212
3. Stein D., and Dutton R. Uses of recombinant factor VIIa in trauma. Curr Opin Crit Care 10 (2004) 520-528
4. Uhlmann E., and Eby C. Recombinant activated factor VII for non-hemophiliac bleeding patients. Curr Opin Hematol 11 (2004) 198-204
5. Freeman W., Brott T., Barrett K., et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 79 (2004) 1495-1500
6. Sorensen B., Johansen P., Nielsen G., Sorensen J., and Ingerslev J. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 14 (2003) 469-477
7. Chuansumrit A., Nuntnarumit P., Okascharoen C., Teeraratkul S., Suwansingh S., and Supapannachart S. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. Pediatrics 110 (2002) 169-171
8. Veldman A., Fischer D., Voigt B., et al. Life-threatening hemorrhage in neonates: management with recombinant activated factor VII. Intensive Care Med 28 (2002) 1635-1637
9. Veneri D., and Franchini M. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient. Am J Hematol 79 (2005) 344-345
10. Bianchi A., Jackson D., Maitz P., and Thanakrishnan G. Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns. Thromb Haemost 91 (2004) 203-204
11. DiDomenico R., Massad M., Kpodonu J., Navarro R., and Geha A. Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass. Chest 127 (2005) 1828-1835
12. Mayo A., Misgav M., Kluger Y., et al. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding. Vox Sanguinis 87 (2004) 34-40
13. Kenet G., Walden R., Eldad A., and Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354 (1999) 27
14. Dutton R., Hess J., and Scalea T. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 15 (2003) 184-188
15. Martinowitz U., Kenet G., Segal E., et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma Inj Infect Crit Care 51 (2001) 431-438
16. O'Neill P., Bluth M., Gloster E., et al. Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy. J Trauma Inj Infect Crit Care 52 (2002) 400-405
17. Lam M., and Sims-McCallum R. Recombinant factor VIIa in the treatment of non-hemophiliac bleeding. Ann Pharmacother 39 (2005) 885-891
18. Levi M., Peters M., and Buller H. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 33 (2005) 883-890
19. Dutton R., McCunn M., Hyder M., et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma Inj Infect Crit Care 57 (2004) 709-718
20. Clark A., Gordon W., Walker I., and Tait R. 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sanguinis 86 (2004) 120-124
21. Goodnough L., Lublin D., Zhang L., Despotis G., and Eby C. Transfusion medicine service policies for recombinant factor VIIa administration. Transfusion 44 (2004) 1325-1331
22. Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med 28 (2002)
23. Bui J., Despotis G., Trulock E., Patterson G., and Goodnough L. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. [see comment]. J Thorac Cardiovasc Surg 124 (2002) 852-854
24. Siegel L., Gerigk L., Tuettenberg J., Dempfle C., Scharf J., and Fiedler F. Cerebral sinus thrombosis in a trauma patient after recombinant activated factor VII infusion. Anesthesiology 100 (2004) 441-443
25. Criddle L., Eldredge D., and Walker J. Variables predicting trauma patient survival following massive transfusion. J Emerg Nurs 31 (2005) 236-242